<DOC>
	<DOCNO>NCT01971177</DOCNO>
	<brief_summary>This clinical study randomize , control , open , prospective , multi-centre , multi-surgeon post-market-clinical-follow-up study investigate impact cataract grade efficacy safety femtosecond laser assist lens fragmentation support phacoemulsification cataractous lens prior intraocular lens ( IOL ) implantation .</brief_summary>
	<brief_title>Addressing Efficacy Safety Femtosecond-laser Assisted Versus Manual Lens Fragmentation Procedure</brief_title>
	<detailed_description>The purpose multi-centre , multi-surgeon , randomize , control , prospective , post-market-clinical-follow-up study clinical study investigate impact cataract grade safety efficacy femtosecond laser assist lens fragmentation cataract surgery use VICTUS femtosecond laser platform . In study patient different cataract grade [ judge lens opacity classification system ( LOCS ) III nuclear opalescence ) randomly assign either manual group laser group , aspects efficacy safety investigate . - The sponsor investigator ensure , relevant document approve institutional review board / institutional ethic committee ( IRB/IEC ) , use institution 's IRB/IEC , approve reviewing central IRB/IEC prior enter subject study . - To avoid potential bias process patient assignment order observe fair true clinical significance block randomization method employ apply study . - Subjects regard enrolled clinical trial population soon sign receive patient inform consent form ( ICF ) underwent preoperative examination . - The sponsor 's clinical group accompany monitor study respect patient enrolment , eligibility control , randomization process , postoperative monitoring data collection accordance applicable regulation specification require sponsor . - All medical information obtain study visit record subject 's record ( source documentation ) real time collect transcribe onto case report form ( CRF ) site personnel .</detailed_description>
	<mesh_term>Cataract</mesh_term>
	<criteria>Patients must read , understood sign Patient Information Patients willing able return followup examination Clear corneal medium Cataract grade ( nuclear ) I V accord LOCS III Patients must least 40 year age Patients present clear lens ( clear lens exchange ) Glaucoma suspect glaucoma Patients preexist proliferative diabetic retinopathy ( mild tight control diabetes symptom , without retinopathy nonproliferative diabetic retinopathy , include . ) Retinal disorder Rheumatic disease Occlusion retinal vessel Pellucid marginal degeneration Herpes zoster herpes simplex keratitis Heavy vascularization ocular tissue Epilepsy Recurrent corneal erosion Severe basement membrane disease Patients suffer severe woundhealing disorder connective tissue disease , autoimmune illness , immunodeficiency illness , endocrine disease , lupus , rheumatoid arthritis , collagenosis , clinically significant atopy Patients suffer AIDS HIV . Chemosis Significant loss stability conjunctiva Nystagmus On keratometric map cornea , minimum maximum Kvalues central 3 mm zone must differ 5 D. The maximum Kvalues must exceed 60 D. The minimum value must small 37 D. Patients pregnant nursing . Patients blind fellow eye . Known sensitivity plan concomitant medication . Patients recurrent active ocular uncontrolled eyelid disease . Subjects poorly dilating pupil . Patients anterior chamber depth ( ACD ) &lt; 1.5 mm ACD &gt; 4.8 mm Presence blood material anterior chamber . A history lens instability ( eg . posterior polar cataract , traumatic cataract ) zonular instability</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>